期刊文献+

导航引导和导航超声造影辅助消融超声显示困难肝癌 被引量:12

Ablation of Hepatocellular Carcinoma Invisible in B-mode Ultrasound Using Navigation and Navigation Assisted Contrast-enhanced Ultrasound
暂未订购
导出
摘要 【目的】探讨导航引导及术中导航超声造影在消融二维超声显示困难肝癌的临床价值。【方法】对34例患者共42个CT/MR提示但二维超声显示困难的肝癌病灶,将超声与CT/MR图像融合后,在导航引导下行射频消融,并于术中使用导航超声造影即时评价消融效果。消融术后1个月行CT/MR评价消融是否完全。【结果】42个病灶的超声-CT/MR图像融合成功率100%(42/42),图像融合用时5~20 min,平均8.5 min。6个病灶(6/42,14.3%)按计划消融后导航超声造影提示消融范围不足,分别再次穿刺1~2针消融。术后1个月CT/MR提示42个病灶均消融完全。【结论】导航能引导消融二维超声显示困难的肝癌病灶,并可辅助超声造影术中即时评价消融效果,达到完全消融病灶的目的。 [Objective] To evaluate the use of navigation and navigation assisted contrast-enhanced ultrasound (CEUS) in ablation of hepatocellular carcinoma (HCC) invisible in B-mode ultrasound. [Methods] Forty-two HCC lesions in 34 patients were enrolled, and all the lesions were diagnosed by CT/MR but invisible in B-mode ultrasound. Eight of the patients had elevated serum AFP. Under general anesthesia, after image fusion between the ultrasound and CT/MR, the navigation system could decide the location and boundary of the HCC in ultrasound image. Radiofrequency ablation (RFA) guided by navigation was applied. By fusing the CT/MR image before RFA with CEUS after RFA, navigation assisted CEUS was employed right after ablation to decide whether the area of ablative zone had covered the whole HCC. Additional puncture was applied if ablative zone had not completely covered the HCC. All the patients received CT/MR one month after ablation to decide whether the HCC had been completely ablated. [ Results] The image fusion was successfully applied in all 42 HCCs, and on average, 8.5 rain (5-20 rain) was spent in image fusion. Six HCCS (6/42, 14.3%) received extra 1 to 2 punctures after navigation assisted CEUS. Haemothorax was found in one patient one day after RFA. Catheter was applied for drainage and was removed after ultrasound revealed no fluid in the chest cavity 4 days later. Twelve patients had asymptomatie pleural effusion or ascites after ablation which disappeared in 1 to 2 weeks. One month after RFA, CT/MR showed that all the HCCs had been completely ablated, and the elevated serum AFP in the 8 patients all fell into normal range. [ Conclusions ] Navigation and navigation assisted CEUS could successfully ablate HCC invisible in B-mode ultrasound.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2012年第4期549-552,共4页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省科技计划项目(2010B031600215)
关键词 肝癌 导航 图像融合 导管消融术 hepatocellular carcinoma navigation image fusion catheter ablation
  • 相关文献

参考文献13

  • 1Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update[J]. Hepatology, 2011, 53(3): 1020-1022.
  • 2刘广健,吕明德,谢晓燕,周旭辉,徐辉雄,匡铭,徐作峰,郑艳玲,梁瑾瑜,黄蓓.实时虚拟导航系统引导消融治疗肝癌[J].中华超声影像学杂志,2006,15(10):758-760. 被引量:15
  • 3蒋天安,陈燕,敖建阳,翁慧芳,陈芬,赵齐羽.实时影像虚拟导航系统在肝癌微创治疗中的初步应用[J].中华超声影像学杂志,2009,18(9):768-771. 被引量:18
  • 4Ewertsen C, Grossjohann HS, Nielsen KR, et al. Biopsy guided by real-time sonography fused with MRI: a phantom study[J]. AJR, 2008, 190(6) : 1671-1674.
  • 5Jung EM, Schreyer AG, Schacherer D, et al. New real- time image fusion technique for characterization of tumor vascularization and tumor perfusion of liver tumors withcontrast-enhanced ultrasound, spiral CT or MRI: first results [J]. Clin Hemorheol Microcirc, 2009, 43 (1): 57-69.
  • 6Ewertsen C, Henriksen BM, Torp-Pedersen S, et al. Characterization by biopsy or CEUS of liver lesions guided by image fusion between uhrasonography and CT, PET/CT or MRI[J]. Uhraschall Med, 2011, 32 (2) : 191-197.
  • 7Ewertsen C. Image fusion between uhrasonography and CT,MRI or PET/CT for image guidance and intervention-a theoretical and clinical study [J ]. Dan Med Bull, 2010, 57(9): B4172.
  • 8Minami Y, Kudo M, Chung H, et al. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images [J]. Oncology, 2007. 72(SuDvl 1) : 111-116.
  • 9Minami Y, Chung H, Kudo M, et al. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation [J]. AJR, 2008, 190(6) : W335-341.
  • 10Kawasoe H, Eguchi Y, Mizuta T, et al. Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by uhrasonography [J]. J Clin Biochem Nutr, 2007, 40 (1): 66-72.

二级参考文献26

  • 1刘广健,吕明德,谢晓燕,周旭辉,徐辉雄,匡铭,徐作峰,郑艳玲,梁瑾瑜,黄蓓.实时虚拟导航系统引导消融治疗肝癌[J].中华超声影像学杂志,2006,15(10):758-760. 被引量:15
  • 2Shiina S, Teratani T,Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology, 2005,129 : 122-130.
  • 3Aramaki M, Kawano K, Ohno T, et al. Microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology, 2004,51 : 1784-1787.
  • 4Iuchi H, Horiike N, Masumoto T, et al. Specially designed needleguided for intercostals puncture of hepatocellular carcinoma seen on computed tomography and not visualized on uhrasonography. Hepatol Res,2003,25:319-328.
  • 5Hertzberg BS, Kliewer MA, Bowie JD, et al. Physician training requirements in sonography:how many cases are needed for competence? Am J Roentgenol, 2000, 174 :1221-1227.
  • 6Maruyama H, Kobayashi S, Yoshizumi H, et al. Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatoeellular carcinoma using microbubble contrast agent. Clin Radiol, 2007,62 : 668-675.
  • 7percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent. Clin Radiol, 2007,62 : 668-675.
  • 8Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared withethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology, 2004,127 : 1714-1723.
  • 9Piscaglia F,Lencioni R,Sagrini E,et al.Characterization of focal liver lesions with contrast-enhanced ultrasound.Ultrasound Med Biol,2010,36:531-550.
  • 10Quaia E,Alaimo V,Baratella E,et al.Effect of observer experience in the differentiation between benign and malignant liver tumors after ultrasound contrast agent injection.J Ultrasound Med,2010,29:25-36.

共引文献35

同被引文献176

引证文献12

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部